Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Interleukin 5, a T-cell-derived B-cell differentiation factor also induces cytotoxic T lymphocytes.
Takatsu K
,
Kikuchi Y
,
Takahashi T
,
Honjo T
,
Matsumoto M
,
Harada N
,
Yamaguchi N
,
Tominaga A
.
Abstract
We describe an interleukin, termed interleukin 5, that is the recombinant product previously referred to as T-cell-replacing factor (TRF), B-cell growth factor II (BCGF II), or killer-helper factor (KHF). TRF has been defined as a T-cell-derived lymphokine that acts on activated B cells as a B-cell differentiation factor. We have previously demonstrated that TRF is identical to BCGF II and induces expression of receptors for interleukin 2 (IL-2) on activated B cells. We also have reported that KHF can induce not only expression of IL-2 receptors on peanut agglutinin-binding (PNA+) thymocytes but also generation of cytotoxic T lymphocytes (CTL) in PNA+ thymocytes in the presence of IL-2. We show here that culture supernatants of T-cell hybridomas that produce TRF as well as TRF purified by high-pressure liquid chromatography (HPLC-TRF) have KHF activity and generate CTL in PNA+ thymocytes in the presence of stimulator cells and IL-2. Moreover, translation products (recombinant TRF) of Xenopus oocytes injected with cDNA encoding for murine TRF (BCGF II) also exert KHF activity. A rat monoclonal anti-TRF antibody TB13 can block generation of CTL by HPLC-TRF or recombinant TRF. These results indicate that TRF acts not only on B cells as BCGF II but also on PNA+ thymocytes as KHF. In view of the diverse activities and targets of TRF, we propose that TRF refers to a different interleukin, interleukin 5.
Chirgwin,
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
1979, Pubmed
Chirgwin,
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.
1979,
Pubmed
Erard,
Characterization of soluble factors that induce the cytolytic activity and the expression of T cell growth factor receptors of a T cell hybrid.
1984,
Pubmed
Falk,
Induction of IL 2 receptor expression and cytotoxicity of thymocytes by stimulation with TCF1.
1985,
Pubmed
Finke,
Splenic T-killer cells can be generated by allogeneic thymic cells in conjunction with assisting factor.
1977,
Pubmed
Finke,
Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2.
1983,
Pubmed
Hamaoka,
Functional characterization of the killer-helper factor responsible for the induction of cytotoxic T lymphocytes from thymocytes, and evidence for the nature of this factor as distinct from T cell-replacing factor (TRF) in regard to B cell triggering.
1981,
Pubmed
Harada,
BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
1985,
Pubmed
Hardt,
Signal requirements for the in vitro differentiation of cytotoxic T lymphocytes (CTL): distinct soluble mediators promote preactivation of CTL-precursors, clonal growth and differentiation into cytotoxic effector cells.
1985,
Pubmed
Howard,
B cell growth and differentiation factors.
1984,
Pubmed
Kanagawa,
Three different signals are required for the induction of cytolytic T lymphocytes from resting precursors.
1983,
Pubmed
Kikuchi,
Generation of cytotoxic T lymphocytes from thymocyte precursors to trinitrophenyl-modified self antigens. II. Establishment of a T cell hybrid clone constitutively producing killer-helper factor(s) (KHF) and functional analysis of released KHF.
1986,
Pubmed
Kinashi,
Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II.
,
Pubmed
Kishimoto,
Factors affecting B-cell growth and differentiation.
1985,
Pubmed
O'Garra,
Interleukin 4 (B-cell growth factor II/eosinophil differentiation factor) is a mitogen and differentiation factor for preactivated murine B lymphocytes.
1986,
Pubmed
Okada,
The differentiation of cytotoxic T cells in vitro. I. Amplifying factor(s) in the primary response is Lyt 1 + cell dependent.
1979,
Pubmed
Okuno,
The role of I-region associated antigen (Ia)-bearing accessory cells in the generation of cytotoxic T cells in a subpopulation of thymocytes.
1986,
Pubmed
Raulet,
A differentiation factor required for the expression of cytotoxic T-cell function.
1982,
Pubmed
Rigby,
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.
1977,
Pubmed
Sanderson,
Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4.
1986,
Pubmed
Schimpl,
Replacement of T-cell function by a T-cell product.
1972,
Pubmed
Shimuzu,
Nucleotide sequence of mouse IL-2 receptor cDNA and its comparison with the human IL-2 receptor sequence.
1985,
Pubmed
Swain,
Role of BCGFII in the differentiation to antibody secretion normal and tumor B cells.
1985,
Pubmed
Swain,
Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays.
1983,
Pubmed
Takatsu,
Biologic significance of disulfide bonds in human IgE molecules.
1975,
Pubmed
Takatsu,
Purification and physicochemical characterization of murine T cell replacing factor (TRF).
1985,
Pubmed
Takatsu,
Generation of cytotoxic T lymphocytes from thymocyte precursors to trinitrophenyl-modified self antigens. I. Requirement of both killer-helper factor(s) and interleukin 2 for CTL generation from a subpopulation of thymocytes.
1986,
Pubmed
Takatsu,
Antigen-induced T cell-replacing factor (TRF). III. Establishment of T cell hybrid clone continuously producing TRF and functional analysis of released TRF.
1980,
Pubmed
Taniguchi,
Structure and expression of a cloned cDNA for human interleukin-2.
,
Pubmed
Thomas,
Hybridization of denatured RNA transferred or dotted nitrocellulose paper.
1983,
Pubmed
,
Xenbase
